发明名称 DRUG DELIVERY SYSTEM USING PEPTIDE MODIFICATION
摘要 <p>It is aimed at developing a method and a system for achieving drug delivery control by using a physiologically active peptide. It has been found out that an unexpected sustained release effect is achieved by adding an amino acid such as glycine to a physiologically active peptide and thus a sustained release system with the use of the amino acid addition has been established. It has been further found out that a composition containing a plural number of modified peptides of the above type has an extremely remarkable sustained release effect. Thus, it is intended to provide a peptide comprising a physiologically active peptide together with at least one amino acid not originating in this physiologically active peptide; and a composition containing at least two types of physiologically active peptide amino acid sequences wherein at least one of them contains at least one amino acid not originating in this physiologically active peptide.</p>
申请公布号 WO2005095443(A1) 申请公布日期 2005.10.13
申请号 WO2005JP06127 申请日期 2005.03.30
申请人 CARDIO INCORPORATED;SAWA, YOSHIKI;TAKETANI, SATOSHI;MIYAGAWA, SHIGERU;TAKAHASHI, JUNZO;MATSUURA, NARIAKI 发明人 SAWA, YOSHIKI;TAKETANI, SATOSHI;MIYAGAWA, SHIGERU;TAKAHASHI, JUNZO;MATSUURA, NARIAKI
分类号 A61K38/00;A61K38/11;A61K38/28;A61K47/18;A61K47/48;A61P3/06;A61P19/00;A61P25/04;A61P25/28;A61P29/00;A61P35/00;C07K7/06;C07K7/08;C07K14/62;(IPC1-7):C07K7/06 主分类号 A61K38/00
代理机构 代理人
主权项
地址